Alzenau, 09/12/2024 – SIGNUS Medizintechnik GmbH is proud to announce the successful FDA approval of TETRIS ® ST and TETRIS ® R ST PLIF cages. These cages, made from structured titanium (ST), combine cutting-edge technology and materials, further expanding the innovative SIGNUS spinal surgery portfolio.
SIGNUS is dedicated to continuously developing products with passion and precision, offering its customers the most advanced solutions. Following the success of the TLIF cages WOMBAT ® ST and MOBIS ® ST, the ST titanium structure is now available for PLIF access.
The SIGNUS ST structure features an open, macroporous titanium design resembling natural cancellous bone architecture, promoting both bone-on growth and bone-ingrowth. This is crucial for long-term implant stability.
TETRIS ® ST features a flattened apex and a self-distracting design that allows implantation without the removal of the posterior vertebral body edges. TETRIS ® R ST offers an additional rotational technique with a tapered rotational edge, enabling a straightforward, low-impact interbody rotation.
Both cages are equipped with the SIGNUS toothed cage design, providing secure anchoring in the bone with high primary stability, which reduces the risk of implant migration.
The approval of TETRIS® ST and TETRIS® R ST is an important step towards completing the ST line of the SIGNUS portfolio. Contact: SIGNUS Medizintechnik GmbH